JANE STREET GROUP, LLC - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 131 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q2 2024$1,780,277
+10.2%
73,112
+52.9%
0.00%
Q1 2024$1,614,780
-28.2%
47,817
-33.0%
0.00%
-100.0%
Q4 2023$2,249,854
+11.5%
71,356
-9.6%
0.00%0.0%
Q3 2023$2,017,530
+37.9%
78,964
+54.8%
0.00%
Q2 2023$1,463,254
+23.8%
51,020
+3.5%
0.00%
Q1 2023$1,182,152
-18.3%
49,318
-42.2%
0.00%
-100.0%
Q4 2022$1,447,401
+214.0%
85,342
+174.8%
0.00%
Q3 2022$461,000
-20.7%
31,052
-15.9%
0.00%
Q2 2022$581,000
-86.2%
36,928
-76.4%
0.00%
-100.0%
Q1 2022$4,225,000
-46.7%
156,709
-26.8%
0.00%
-66.7%
Q4 2021$7,926,000
-28.1%
214,153
-7.2%
0.00%
-25.0%
Q3 2021$11,028,000
+242.5%
230,798
+142.6%
0.00%
+300.0%
Q2 2021$3,220,000
-56.2%
95,150
-46.6%
0.00%
-66.7%
Q1 2021$7,356,000
-57.6%
178,100
-55.5%
0.00%
-66.7%
Q4 2020$17,366,000
+49.1%
400,326
+47.5%
0.01%
+28.6%
Q3 2020$11,646,000
+13.4%
271,456
+23.5%
0.01%0.0%
Q2 2020$10,273,000
+4025.7%
219,788
+1099.3%
0.01%
Q1 2020$249,00018,3270.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q2 2022
NameSharesValueWeighting ↓
Portolan Capital Management 484,907$11,807,4850.97%
Nikko Asset Management Americas, Inc. 1,563,065$37,966,8490.44%
Diametric Capital, LP 32,765$797,8270.43%
ARK Investment Management 1,964,964$47,846,8710.42%
SummerHaven Investment Management, LLC 23,400$569,7900.38%
Quantedge Capital Pte Ltd 40,800$993,4800.36%
Granahan Investment Management 344,549$8,389,7680.34%
FEDERATED HERMES, INC. 4,694,060$114,300,3610.27%
Belmont Capital, LLC 40,000$974,0000.18%
Woodline Partners LP 754,023$18,360,4600.18%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders